Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002568259 | SCV003459999 | uncertain significance | Ataxia-telangiectasia syndrome | 2022-03-04 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 2861 of the ATM protein (p.Ile2861Thr). This variant has not been reported in the literature in individuals affected with ATM-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1184266). |
Medical Genetics Laboratory, |
RCV001542251 | SCV001759969 | likely pathogenic | Multifocal breast carcinoma | 2021-07-21 | no assertion criteria provided | clinical testing | Diagnosis: Triple Negative Bilateral Breast Cancer Pathology: Invasive Lobular Ca IHC: ER+, PR %1, HER2(Scor2), CK+, Ecaderin- KI67:%30 |
Medical Genetics Laboratory, |
RCV001568365 | SCV001792250 | likely pathogenic | Breast carcinoma | 2021-08-18 | no assertion criteria provided | clinical testing | Invasive Ductal Carcinoma |